Imr+e Corpon

Company Information

Company Name
Imr+e Corpon
Address
130 Fifth Avenue North
Seattle, WA, 98109
Phone
n/a
URL
n/a
DUNS
n/a
Number of Employees
n/a

Award Totals

PROGRAM/PHASE
AWARD AMOUNT ($)
NUMBER OF AWARDS
SBIR Phase I
$222,424.00
5
Chart code to be here

Award List

  1. SEVERAL RECENT REPORTS SUGGEST THAT EXTRACORPOREAL PERFUSION OF TUMOR BEARING PLASMA OVER PROTEIN A CONTAINING SUBSTRATES CAN RESULT IN OBJECTIVE TUMOR REGRESSION IN THE HOST.

    Amount: $45,720.00

    SEVERAL RECENT REPORTS SUGGEST THAT EXTRACORPOREAL PERFUSION OF TUMOR BEARING PLASMA OVER PROTEIN A CONTAINING SUBSTRATES CAN RESULT IN OBJECTIVE TUMOR REGRESSION IN THE HOST. IN THE PRESENT INVESTIGA ...

    SBIR Phase I 1984 Department of Health and Human Services
  2. WE HAVE REPORTED THAT EXTRACORPOREAL IMMUNOADSORPTION TO REMOVE CIRCULATING IMMUNE COMPLEXES (CIC) AND IGG RESULTS IN COMPLETE REGRESSION OF FELINE LYMPHOSARCOMA, CLEARANCE OF PERSISTANT FELINE LEUKEMIA VIRUS INFECTION AND HISTOLOGIC CHANGES ASSOCIATED

    Amount: $50,000.00

    WE HAVE REPORTED THAT EXTRACORPOREAL IMMUNOADSORPTION TO REMOVE CIRCULATING IMMUNE COMPLEXES (CIC) AND IGG RESULTS IN COMPLETE REGRESSION OF FELINE LYMPHOSARCOMA, CLEARANCE OF PERSISTANT FELINE LEUKEM ...

    SBIR Phase I 1984 Department of Health and Human Services
  3. THE OBJECTIVE OF THE PROPOSED RESEARCH IS TO DEVELOP AN IMMUNOLOGICALLY SPECIFIC ADSORBENT FOR USE IN EXTRACORPOREALSYSTEMS TO REMOVE IMMUNOREACTIVE IGM FROM THE SERUM OF PATIENTS FOR PRIMARY BILIARY CIRRHOSIS (PBC).

    Amount: $26,704.00

    THE OBJECTIVE OF THE PROPOSED RESEARCH IS TO DEVELOP AN IMMUNOLOGICALLY SPECIFIC ADSORBENT FOR USE IN EXTRACORPOREALSYSTEMS TO REMOVE IMMUNOREACTIVE IGM FROM THE SERUM OF PATIENTS FOR PRIMARY BILIARY ...

    SBIR Phase I 1983 Department of Health and Human Services
  4. A SERIES OF FUCOSYLATED GLYCOSPHINGOLIPIDS WITH THE ""X'' DETERMINANT (GAL 1 4FUC 1 3GLCNAC) HAVE BEEN SHOWN TO ACCUMULATE IN HUMAN COLONIC AND LIVER ADENOCARCINOMA AND ARE VIRTUALLY ABSENT IN NORMAL COLONIC MUCOSA AND NORMAL LIVER TISSUE.

    Amount: $50,000.00

    A SERIES OF FUCOSYLATED GLYCOSPHINGOLIPIDS WITH THE ""X'' DETERMINANT (GAL 1 4FUC 1 3GLCNAC) HAVE BEEN SHOWN TO ACCUMULATE IN HUMAN COLONIC AND LIVER ADENOCARCINOMA AND ARE VIRTUALLY ABSENT IN NORMAL ...

    SBIR Phase I 1985 Department of Health and Human Services
  5. EASIER TO CONJUGATE TO ANTIBODIES WITH HIGHER REPRODUCIBILITY.

    Amount: $50,000.00

    EASIER TO CONJUGATE TO ANTIBODIES WITH HIGHER REPRODUCIBILITY.THE AIM OF THIS RESEARCH IS TO ISOLATE AND CHARACTERIZE ANTIGENS IN CIRCULATING IMMUNE COMPLEXES (CIC) FROM PATIENTS WITH ACQUIRED IMMUNOD ...

    SBIR Phase I 1985 Department of Health and Human Services

Agency Micro-sites


SBA logo

Department of Agriculture logo

Department of Commerce logo

Department of Defense logo

Department of Education logo

Department of Energy logo

Department of Health and Human Services logo

Department of Homeland Security logo

Department of Transportation logo

Enviromental Protection Agency logo

National Aeronautics and Space Administration logo

National Science Foundation logo
US Flag An Official Website of the United States Government